CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter
This article was originally published in The Gray Sheet
Executive Summary
Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO